Search - tctmd.com

Displaying 101 - 120 of 555

Sort: Relevancy | Date

Presentation TCT 2023

TCT 770: Women Undergoing High-Risk PCI Have Better 12-Month Survival Despite Higher Complexity of Coronary Artery Disease: Insights From the IMPELLA-PL Registry

Presenter: Aleksandra Gasecka

October 25, 2023

Presentation TCT 2023

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

Presenter: Kirstine Hansen

October 25, 2023

Presentation TCT 2023

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

Presenter: Rayyan Hemetsberger

October 25, 2023

Presentation TCT 2023

Treatment of Aortic Regurgitation Using Dedicated TAVR Systems: Early European Experiences and Description of the Align AR Trial

Presenter: Stephan Baldus

October 25, 2023

Presentation TCT 2023

TCT 185: Safety and Performance Registry for an All-Comers Subject Population with the Limus Eluting Orsiro Mission Stent System Within Daily Clinical Practice: Twelve-Month Results of the BIOFLOW-VIII Registry

Presenter: Georg Nollert

October 25, 2023

Presentation TCT 2023

AGENT-IDE Data Dive: Background, Trial Design, and Primary Results

Presenter: Robert Yeh

October 25, 2023

Presentation TCT 2023

TCT 522: Ultrathin Strut Biodegradable Polymer-coated Sirolimus-eluting Stents in an All-comers Patient Population – The Prospective S-FLEX UK-II Registry

Presenter: Azfar Zaman

October 25, 2023

Presentation TCT 2023

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Jens Trøan

October 25, 2023

Presentation TCT 2023

TCT 662: Long-term Clinical Outcomes from 2 European Centres Following the Use of Sirolimus-Coated Balloon in Small Vessel and Long-Lesions in De-novo Segments

Presenter: Sandeep Basavarajaiah

October 25, 2023

Presentation TCT 2023

TCT 677: Direct Comparison of Zotarolimus Eluting Stents vs Everolimus Eluting Stents Stratified by Follow-ups: An Updated Meta-analysis of Randomized Controlled Trials

Presenter: Usman Naseer

October 25, 2023

Presentation TCT 2023

TCT 424: In Vitro Investigation of Polymer Damage on Drug-Eluting Stents Resulting from Intravascular Lithotripsy

Presenter: Doosup Shin

October 25, 2023

Presentation TCT 2023

TCT 476: Biological Differences of Three Paclitaxel- and Sirolimus-coated Balloons on Coronary Lesions in a Rabbit Model

Presenter: Kazuki Aihara

October 25, 2023

Presentation TCT 2023

TCT 280: Treatment of Calcified Coronary Lesions With Contemporary Drug-Coated Balloons

Presenter: Florim Cuculi

October 25, 2023

Presentation TCT 2023

Pantera Lux

Presenter: Ron Waksman

October 25, 2023

Presentation TCT 2023

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

Presenter: Eline Ploumen

October 25, 2023

Presentation TCT 2023

TCT 128: Treatment of Coronary Artery Disease with Sirolimus- Versus Paclitaxel-Coated Balloons

Presenter: Matthias Bossard

October 25, 2023

Presentation TCT 2023

Agent DCB

Presenter: Robert Yeh

October 25, 2023

Presentation TCT 2023

TCT 117: Long Term Outcomes Following Treatment of Chronic Total Occlusions using Drug-Coated Ballooons

Presenter: Florim Cuculi

October 25, 2023

Presentation TCT 2023

Magic Touch

Presenter: Bernardo Cortese

October 25, 2023

Presentation TCT 2023

Prevail Paclitaxel Coated Balloon

Presenter: Jack Tan

October 25, 2023

Advertisement

TCT 770: Women Undergoing High-Risk PCI Have Better 12-Month Survival Despite Higher Complexity of Coronary Artery Disease: Insights From the IMPELLA-PL Registry

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

Treatment of Aortic Regurgitation Using Dedicated TAVR Systems: Early European Experiences and Description of the Align AR Trial

TCT 185: Safety and Performance Registry for an All-Comers Subject Population with the Limus Eluting Orsiro Mission Stent System Within Daily Clinical Practice: Twelve-Month Results of the BIOFLOW-VIII Registry

AGENT-IDE Data Dive: Background, Trial Design, and Primary Results

TCT 522: Ultrathin Strut Biodegradable Polymer-coated Sirolimus-eluting Stents in an All-comers Patient Population – The Prospective S-FLEX UK-II Registry

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

TCT 662: Long-term Clinical Outcomes from 2 European Centres Following the Use of Sirolimus-Coated Balloon in Small Vessel and Long-Lesions in De-novo Segments

TCT 677: Direct Comparison of Zotarolimus Eluting Stents vs Everolimus Eluting Stents Stratified by Follow-ups: An Updated Meta-analysis of Randomized Controlled Trials

TCT 424: In Vitro Investigation of Polymer Damage on Drug-Eluting Stents Resulting from Intravascular Lithotripsy

TCT 476: Biological Differences of Three Paclitaxel- and Sirolimus-coated Balloons on Coronary Lesions in a Rabbit Model

TCT 280: Treatment of Calcified Coronary Lesions With Contemporary Drug-Coated Balloons

Pantera Lux

TCT 518: Final 5-year report of the randomized BIONYX trial assessing Onyx versus Orsiro drug-eluting stents in all-comers

TCT 128: Treatment of Coronary Artery Disease with Sirolimus- Versus Paclitaxel-Coated Balloons

Agent DCB

TCT 117: Long Term Outcomes Following Treatment of Chronic Total Occlusions using Drug-Coated Ballooons

Magic Touch

Prevail Paclitaxel Coated Balloon

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content